CD5 and neoplasm: Further, He et al. validated older observations of reduced CD5 expression in the TME compared to healthy tissue, hinting at a tumor-induced downregulation.4 The parallel to specific modulation of known immune checkpoint molecules like PD-1 in the TME is striking.